Arrhythmia Research Technology, Inc. (AMEX:HRT)
CAPS Rating:
The Company is engaged in the development and licensing of medical software, which acquires data and analyzes electrical impulses of the heart to detect and aid in the treatment of potentially lethal arrhythmias.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No players have picked HRT yet. Tell us why you think HRT will outperform or underperform the market.
RSS Headlines
Fool UK